Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Zealand Pharma announces Boehringer Ingelheim's survodutide Phase III trial in people living with obesity showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis
Company announcement No. 21 / 2026 Zealand Pharma announces Boehringer Ingelheim's survodutide Phase III trial showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis, supporting improved…
Mizuho Strategist: Healthcare Is Now a Value Sector as Pharma Stocks Underperform Tech
After years of lagging the market, healthcare may be taking on a new role in investor portfolios. Speaking on CNBC, Mizuho healthcare strategist Jared Holz reframed the sector, arguing that years of underperformance have turned drug stocks from a…
Royalty Pharma PLC $RPRX Shares Purchased by Capital International Investors
Capital International Investors grew its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 14.3% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The…
Capital International Sarl Purchases 166,334 Shares of Royalty Pharma PLC $RPRX
Capital International Sarl lifted its position in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 45.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission.
Royalty Pharma PLC $RPRX Shares Acquired by Capital International Ltd. CA
Capital International Ltd. CA lifted its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 47.6% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 301,623…
Los Angeles Capital Management LLC Purchases 212,294 Shares of Royalty Pharma PLC $RPRX
Los Angeles Capital Management LLC lifted its stake in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 20.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The…
Capital Group Investment Management PTE. LTD. Has $2.53 Million Stake in Royalty Pharma PLC $RPRX
Capital Group Investment Management PTE. LTD. increased its position in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 44.5% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 65,513 shares of the…
New data may cast doubt on competitiveness of Boehringer's obesity drug
New data on Boehringer Ingelheim's obesity candidate suggest the drug may be helpful in cutting liver fat, but it's not clear how competitive the treatment would be since it appears less efficacious and less tolerable than drugs on the market. In a…
Aclaris Therapeutics, Inc. (ACRS): A Top Penny Stock in Investors Portfolio That Stifel is Bullish On
Aclaris Therapeutics Inc. (NASDAQ: ACRS) is one of the top penny stocks to buy in investors' stock portfolio. On May 8, Stifel reiterated a Hold rating on Aclaris Therapeutics Inc. (NASDAQ:ACRS) and increased the price target to $4 from $3. The…
Boehringer Ingelheim's survodutide Phase III trial showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis, supporting improved metabolic health in people living with obesity
News builds on previously announced positive topline results from SYNCHRONIZE-1 76-week trial, which met its primary endpoints and showed up to 16.6% weight loss with survodutide, a novel glucagon/GLP-1 dual agonist, from baseline. …
Is Vir Biotechnology, Inc. (VIR) A Good Stock To Buy Now?
Is VIR a good stock to buy? We came across a bullish thesis on Vir Biotechnology, Inc. on Valueinvestorsclub.com by Bohr. In this article, we will summarize the bulls' thesis on VIR. Vir Biotechnology, Inc.'s share was trading at $9.19 as of May…
How Trump accidentally declared war on Mar-a-Lago Face
On the night of February 28, Mar-a-Lago hosted two parties at once. On one side of the Palm Beach estate, guests in gowns and black tie sipped cocktails by the pool at a charity gala. On the other, the President of the United States started a war.
Is Veeva Systems Inc. (VEEV) A Good Stock To Buy Now?
Is VEEV a good stock to buy? We came across a bullish thesis on Veeva Systems Inc. on X.com by @tomicki. In this article, we will summarize the bulls' thesis on VEEV. Veeva Systems Inc.'s share was trading at $188.66 as of June 1. VEEV's trailing…
PM Modi's visit to Jakarta discussed: India, Indonesia deepen cooperation in defence, maritime security
3 min read New Delhi Make us preferred source on Google External Affairs Minister S Jaishankar and his Indonesia counterpart Sugiono held bilateral talks on Sunday as the two nations agreed to advance cooperation in defence, maritime security…
Teva Pharmaceutical Industries Ltd. $TEVA Shares Sold by BNP Paribas Financial Markets
BNP Paribas Financial Markets trimmed its holdings in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Free Report) by 10.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm…
Receive a Daily briefing on Pharma Industry News
Get Started